FDA Inspection 1262276 - Alnylam Pharmaceuticals Inc. - February 25, 2025

View on Dashboard

Discuss this record with AI

ChatGPT

Claude

Perplexity

Grok

Copilot

Record Details

This FDA Inspection record concerns Alnylam Pharmaceuticals Inc., with an inspection on February 25, 2025, issued by the New England District Office, covering human drugs.

Company: Alnylam Pharmaceuticals Inc.
Inspection Date: February 25, 2025
Product Type: Human Drugs
Office: New England District Office

Open in Dashboard

ID · f171eb1e-7893-4b06-a4b1-a428da24972b

Violation Codes3

21 CFR 211.180(b)21 CFR 211.19221 CFR 211.84(d)(2)

Full citation text and observation details available on the Dashboard.